Zhaolin Yang
About Zhaolin Yang
Zhaolin Yang is a Scientist I at the Broad Institute of MIT and Harvard, specializing in biochemistry and biophysics with a focus on cancer research. He holds a PhD in Life Sciences from Université Grenoble Alpes and has extensive experience in molecular interactions and CRISPR screening.
Work at Broad Institute
Zhaolin Yang has been employed at the Broad Institute of MIT and Harvard as a Scientist I since 2021. In this role, he contributes to ongoing research initiatives, focusing on cancer research. His work aims to enhance the understanding of cancer biology and improve treatment methodologies. The Broad Institute is known for its collaborative environment and innovative approaches in biomedical research, providing a platform for Yang to apply his expertise in biochemistry and biophysics.
Education and Expertise
Zhaolin Yang holds a Doctor of Philosophy (PhD) in Life Sciences from Université Grenoble Alpes, where he studied from 2010 to 2016. He also earned a Bachelor of Science (BS) in Biology/Biological Sciences from Shandong University (2002-2006) and a Master of Science (MS) in Cell/Cellular and Molecular Biology from Uppsala University (2008-2010). Additionally, he completed a Master of Science (MS) in Biochemistry and Molecular Biology at Zhejiang University (2006-2008). His educational background equips him with strong skills in biochemistry and biophysics, as well as expertise in CRISPR screening technology.
Background
Before joining the Broad Institute, Zhaolin Yang worked at Cold Spring Harbor Laboratory as a postdoctoral researcher from 2016 to 2021. His earlier experience includes a position as a Master's student at Uppsala University in 2009 and a PhD position at EMBL in Grenoble, France, from 2010 to 2016. Yang's diverse academic and research experiences span multiple countries, including Sweden, France, and the United States, reflecting his international exposure in the field of life sciences.
Research Focus
Zhaolin Yang's research primarily focuses on cancer research, where he aims to advance the understanding and treatment of the disease. His expertise in biochemistry and biophysics supports his investigations into molecular interactions that are critical for cancer biology. Yang employs cutting-edge technologies, including CRISPR screening, to explore genetic factors that contribute to cancer progression and treatment responses.